EQ
Closed
Equillium Inc
0.315
0.000 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.3152
Day's Range: 0.31 - 0.34
Send
sign up or login to leave a comment!
When Written:
0.73
Equillium Inc is a clinical-stage biotechnology company that is focused on developing treatments for severe autoimmune and inflammatory disorders. The company's lead product candidate is EQ001, a monoclonal antibody that targets the CD6 protein, which is involved in regulating the immune system. EQ001 is being developed as a potential treatment for a range of autoimmune and inflammatory disorders, including acute graft-versus-host disease, lupus nephritis, and uncontrolled asthma. Equillium was founded in 2017 and is headquartered in La Jolla, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








